Adicet Bio, Inc. Proceeds from Stock Options Exercised
Adicet Bio, Inc. (ACET) reported Proceeds from Stock Options Exercised of $1.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-08-05
- Adicet Bio, Inc. proceeds from stock options exercised for the quarter ending 2025-12-31 was $1.00K.
- Adicet Bio, Inc. proceeds from stock options exercised for the quarter ending 2025-09-30 was $0.00.
- Adicet Bio, Inc. proceeds from stock options exercised for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Adicet Bio, Inc. proceeds from stock options exercised for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Adicet Bio, Inc. proceeds from stock options exercised for fiscal 2025 was $1.00K, a 99.49% decline from fiscal 2024.
- Adicet Bio, Inc. proceeds from stock options exercised for fiscal 2024 was $195.00K, a 4775.00% increase from fiscal 2023.
- Adicet Bio, Inc. proceeds from stock options exercised for fiscal 2023 was $4.00K, a 99.70% decline from fiscal 2022.
- Adicet Bio, Inc. proceeds from stock options exercised for fiscal 2022 was $1.31M, a 71.95% decline from fiscal 2021.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 9 month as first filed | Proceeds from Stock Options Exercised 12 month | Proceeds from Stock Options Exercised 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.00K 10-Q · filed 2026-08-05 | |||||
| 2025-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.00K derived: sum of 2 quarters · filed 2026-03-12 | $1.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.00K 10-K · filed 2026-03-12 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2026-08-05 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $6.00K derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $6.00K derived: sum of 3 quarters · filed 2026-03-12 | $195.00K 10-K · filed 2026-03-12 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $6.00K derived: sum of 2 quarters · filed 2025-11-05 | $195.00K 10-Q · filed 2025-11-05 | $195.00K derived: sum of 4 quarters · filed 2025-11-05 | ||
| 2024-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $195.00K 10-Q · filed 2025-08-07 | $195.00K derived: sum of 3 quarters · filed 2025-08-07 | $195.00K derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $189.00K 10-Q · filed 2025-05-06 | $189.00K derived: sum of 2 quarters · filed 2025-05-06 | $189.00K derived: sum of 3 quarters · filed 2025-05-06 | $190.00K derived: sum of 4 quarters · filed 2025-05-06 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 derived: sum of 2 quarters · filed 2025-03-06 | $1.00K derived: sum of 3 quarters · filed 2025-03-06 | $4.00K 10-K · filed 2025-03-06 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $1.00K derived: sum of 2 quarters · filed 2024-11-06 | $4.00K 10-Q · filed 2024-11-06 | $851.00K derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $4.00K 10-Q · filed 2024-08-13 | $851.00K derived: sum of 3 quarters · filed 2024-08-13 | $1.04M derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $3.00K 10-Q · filed 2024-05-14 | $850.00K derived: sum of 2 quarters · filed 2024-05-14 | $1.04M derived: sum of 3 quarters · filed 2024-05-14 | $1.22M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $847.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $1.04M derived: sum of 2 quarters · filed 2024-03-19 | $1.22M derived: sum of 3 quarters · filed 2024-03-19 | $1.31M 10-K · filed 2024-03-19 | ||
| 2022-09-30 | $191.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $374.00K derived: sum of 2 quarters · filed 2023-11-08 | $468.00K 10-Q · filed 2023-11-08 | $3.53M derived: sum of 4 quarters · filed 2023-11-08 | ||
| 2022-06-30 | $183.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $277.00K 10-Q · filed 2023-08-09 | $3.34M derived: sum of 3 quarters · filed 2023-08-09 | $3.71M derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | $94.00K 10-Q · filed 2023-05-09 | $3.16M derived: sum of 2 quarters · filed 2023-05-09 | $3.53M derived: sum of 3 quarters · filed 2023-05-09 | $3.81M derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | $3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $3.43M derived: sum of 2 quarters · filed 2023-03-15 | $3.71M derived: sum of 3 quarters · filed 2023-03-15 | $4.69M 10-K · filed 2023-03-15 | ||
| 2021-09-30 | $367.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $646.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.62M 10-Q · filed 2022-11-08 | $1.89M derived: sum of 4 quarters · filed 2022-11-08 | ||
| 2021-06-30 | $279.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $1.25M 10-Q · filed 2022-08-10 | $1.52M derived: sum of 3 quarters · filed 2022-08-10 | $1.67M derived: sum of 4 quarters · filed 2022-08-10 | ||
| 2021-03-31 | $976.00K 10-Q · filed 2022-05-12 | $1.24M derived: sum of 2 quarters · filed 2022-05-12 | $1.39M derived: sum of 3 quarters · filed 2022-05-12 | $1.39M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $267.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $411.00K derived: sum of 2 quarters · filed 2022-03-15 | $418.00K derived: sum of 3 quarters · filed 2022-03-15 | $460.00K 10-K · filed 2022-03-15 | ||
| 2020-09-30 | $144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $151.00K derived: sum of 2 quarters · filed 2021-11-10 | $193.00K 10-Q · filed 2021-11-10 | $199.00K derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $49.00K 10-Q · filed 2021-08-12 | $55.00K derived: sum of 3 quarters · filed 2021-08-12 | |||
| 2020-03-31 | $42.00K 10-Q · filed 2021-05-17 | $48.00K derived: sum of 2 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $30.00K 10-K · filed 2021-03-12 | $6.00K 10-K · filed 2020-03-12 | |||
| 2019-09-30 | $24.00K 10-Q · filed 2020-11-05 | $6.00K 10-Q · filed 2019-11-05 | ||||
| 2018-12-31 | $221.00K 10-K · filed 2021-03-12 | $5.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |